Le Lézard
Classified in: Health
Subjects: MAV, PER, CFG

NOTICE TO THE MEDIA - Government of Canada to make an announcement on oral health care for Canadians


OTTAWA, ON, Dec. 8, 2023 /CNW/ -

The Honourable Mark Holland, Minister of Health, the Honourable Terry Beech, Minister of Citizens' Services, the Honourable Jean-Yves Duclos, Minister of Public Services and Procurement Canada, and the Honourable Seamus O'Regan Jr., Minister of Labour and Seniors, will hold a press conference to make an important announcement on oral health care. 

Participants will be available to answer questions from the media following their remarks.

Cameras will be invited to a photo opportunity before the press conference begins.

There will be a virtual media technical briefing with Government of Canada officials prior to the press conference.

Date
December 11, 2023

Time

Virutal technical briefing: 8:30 AM (EST)

Photo opportunity: 10:00 AM (EST)

Ministerial press conference: 10:30 AM (EST) 

Location

Ministerial photo opportunity and press conference:
Algonquin College, Nawapon Room
1385 Woodroffe Avenue
Building C
Nepean, Ontario

Media may also join the event by Zoom.

To obtain the link to the event and the briefing material under embargo, please communicate by email at [email protected].

The technical briefing will also be held on Zoom and will be for background information only (not for attribution). The content of the technical briefing will be under embargo until the press conference starts at 10:30 AM.

Participation in the question and answer portion of the technical briefing is for accredited members of the Press Gallery only. The Press Gallery will provide the link to the Zoom for the technical briefing. Media who are not members of the Press Gallery may contact [email protected] for temporary access.

NOTE: To help ensure optimal simultaneous interpretation sound quality, journalists are encouraged to use a microphone (headphones/headset) or, when possible, a landline, and to avoid using speaker mode if queuing up for questions.

A teleconference line is also available for listening to the technical briefing:

Toll-free dial-in number (Canada/US):
1-866-206-0153

Local dial-in number:
613-954-9003

Participant passcode: 6997834#

X (formerly Twitter): @GovCanHealth
Facebook: Healthy Canadians

Media Inquiries:

Christopher Aoun
Press Secretary
Office of the Honourable Mark Holland
Minister of Health
613-291-4176
[email protected]

Erik Nosaluk? 
Director of Communications? 
Office of the Minister of Citizens' Services, Terry Beech? 
[email protected]

Olivier Pilon
Press Secretary
Office of the Honourable Jean-Yves Duclos
613-323-6621
[email protected] 

Hartley Witten
Press Secretary and Senior Communications Advisor
Office of the Minister of Labour and Seniors, Seamus O'Regan Jr.
343-575-1065
[email protected]

Media Relations
Health Canada
613-957-2983
[email protected]

Media Relations
Employment and Social Development Canada
819-994-5559
[email protected]

Media Relations
Canada Revenue Agency
613-948-8366
[email protected]

Media Relations
Public Services and Procurement Canada
819-420-5501
[email protected]

SOURCE Health Canada (HC)


These press releases may also interest you

at 17:31
EDETEK, a leading provider of innovative clinical trial solutions, is proud to announce the release of CONFORMtm eClinical Version 5.1. This latest version offers a fully integrated suite of components designed to streamline and enhance the clinical...

at 17:30
Premier Health of America Inc. (the "Corporation"), a leading Canadian Healthtech company, announces it has filed its Unaudited Quarterly Consolidated Financial Statements and MD&A for its second quarter ended on March 31st, 2024. Highlights(in...

at 17:30
Aadi Bioscience, Inc. , a commercial-stage precision oncology company focused on developing and commercializing therapies for cancers with...

at 17:30
Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address oncogenic and immune dysregulation that drive cancer, today announced that clinical and biomarker data...

at 17:27
EDETEK, a leading provider of innovative clinical trial solutions, is excited to announce the launching of the Continuous Study Monitoring module within the CONFORMtm Informatics platform. This new module supports both rule-based and unsupervised...

at 17:20
Puma Biotechnology, Inc. , a biopharmaceutical company, announced the release of abstracts on alisertib to be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. The ASCO Annual Meeting will be held at McCormick Place...



News published on and distributed by: